$HUTCHMED(00013)$ This stock is seriously undervalued! The ATTC platform has been in development for over three years, and the company sold off its cash cow, the traditional Chinese medicine business, just to double down on this platform, the potential is massive.
The stock is at a historic low right now, and with the first drug from this platform entering clinical trials by the end of the year, if the results are positive, we’re looking at a major breakout. I’ve already started building my position, just waiting for the data to roll in, it’s going to be a huge opportunity!
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments